JP2005330228A - Hair growth inhibitor, skin care preparation and cosmetic each compounded therewith - Google Patents
Hair growth inhibitor, skin care preparation and cosmetic each compounded therewith Download PDFInfo
- Publication number
- JP2005330228A JP2005330228A JP2004150246A JP2004150246A JP2005330228A JP 2005330228 A JP2005330228 A JP 2005330228A JP 2004150246 A JP2004150246 A JP 2004150246A JP 2004150246 A JP2004150246 A JP 2004150246A JP 2005330228 A JP2005330228 A JP 2005330228A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- hair
- hair growth
- growth inhibitor
- nettle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003779 hair growth Effects 0.000 title claims abstract description 37
- 239000003966 growth inhibitor Substances 0.000 title claims abstract description 22
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 53
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 235000009108 Urtica dioica Nutrition 0.000 claims description 30
- 241000218691 Cupressaceae Species 0.000 claims description 5
- 244000274883 Urtica dioica Species 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 abstract description 4
- 241000596154 Belamcanda Species 0.000 abstract description 3
- 241000674251 Urtica laetevirens Species 0.000 abstract 1
- 241000219422 Urtica Species 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 235000019441 ethanol Nutrition 0.000 description 14
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 13
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 11
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000218645 Cedrus Species 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 230000003660 hair regeneration Effects 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229940069780 barley extract Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 229940007061 capsicum extract Drugs 0.000 description 3
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000023750 transforming growth factor beta production Effects 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- XUDNWQSXPROHLK-OACYRQNASA-N 2-phenyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC=CC=2)OC2=CC=CC=C2C1=O XUDNWQSXPROHLK-OACYRQNASA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241000218215 Urticaceae Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000003659 hair regrowth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 102000057308 human HGF Human genes 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000002488 outer root sheath cell Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、体毛の毛成長抑制剤に関する。 The present invention relates to a hair growth inhibitor for body hair.
近年、手、足、腋等における体毛は美的外観上、無い方が好ましいとする傾向が高まり、このため各種の体毛除去方法が開発され、利用されている。具体的にはシェーバー、抜毛器等を用いる機械的除去方法、脱毛剤を用いて体毛を毛根から抜毛する方法、除毛剤を用いてその化学的作用により体毛を除去する方法などが挙げられる。 In recent years, there is an increasing tendency that hair in hands, feet, heels and the like is preferable in terms of aesthetic appearance, and various hair removal methods have been developed and used. Specific examples include a mechanical removal method using a shaver, hair remover, etc., a method of removing hair from the hair root using a hair removal agent, and a method of removing body hair by its chemical action using a hair removal agent.
しかしながら、これらの体毛除去方法は、皮膚に対して物理的または化学的刺激を伴うものであり、また、体毛除去方法によっては多少の差はあるものの体毛除去効果の持続性には限度がある。このため、一定期間経過後には再び体毛除去処理を行わなければならず、体毛除去処理の軽減化が望まれている。 However, these hair removal methods involve physical or chemical irritation to the skin, and the durability of the hair removal effect is limited although there are some differences depending on the hair removal method. For this reason, the hair removal process must be performed again after a certain period of time, and reduction of the hair removal process is desired.
このような観点から、毛成長を抑制する抑制剤が開発されており、そのような抑制剤に関する特許出願として、たとえば下記特許文献1のような出願がなされている。この特許文献1に記載された毛成長の抑制剤は、パントテン酸を配合したものである。
しかしながら、この特許文献1には、パントテン酸が毛成長を抑制する作用について明確に記載されておらず、毛の量を秤量することによる試験結果が開示されているのみで、その効果の有用性も定かではない。 However, this Patent Document 1 does not clearly describe the action of pantothenic acid to suppress hair growth, and only discloses the test results obtained by weighing the amount of hair. Not sure.
一方、毛成長抑制剤及びその抑制剤を配合した化粧料に関する特許出願として下記特許文献2のような出願もなされている。この特許文献2に記載された毛成長抑制剤は、フラボノール配糖体を有効成分とするものである。
この特許文献2には、不死化ヒト外毛根鞘細胞の増殖抑制試験により、その細胞増殖抑制率を算出して増殖抑制の効果が示されている。しかし、この特許文献2においても、
毛成長を抑制する作用については定かでなく、効果についても十分とは必ずしも認められない。
This Patent Document 2 shows the effect of inhibiting growth by calculating the cell growth inhibition rate by a growth inhibition test of immortalized human outer root sheath cells. However, also in this patent document 2,
The effect of suppressing hair growth is not clear, and the effect is not always sufficient.
本発明は、このような問題を解決するためになされたもので、体毛除去処理の軽減化を図ることのできる毛成長抑制剤、並びにその毛成長抑制剤を配合した皮膚外用剤及び化粧料を提供することを課題とする。 The present invention has been made in order to solve such problems, and includes a hair growth inhibitor capable of reducing body hair removal treatment, and a skin external preparation and a cosmetic containing the hair growth inhibitor. The issue is to provide.
体毛の毛根には毛乳頭と称される組織があり、毛乳頭が種々のサイトカインを産生することにより、毛成長をコントロールすることが近年報告されている。毛成長を促進するサイトカインとしては、HGF(肝細胞増殖因子)、IGF−I(インシュリン様成長因子−I)などがあり、また毛成長を抑制するサイトカインとしてTGF−β(トランスフォーミング成長因子−β)などがある。従って、毛乳頭が産生するHGFなどの毛成長を促進するサイトカインの産生を抑制させること、あるいは、TGF−βなどの毛成長を抑制するサイトカインの産生を促進させることにより、体毛の成長を抑制することができると考えられる。 There is a tissue called a hair papilla in the hair root of body hair, and it has recently been reported that the hair papilla produces various cytokines to control hair growth. Examples of cytokines that promote hair growth include HGF (hepatocyte growth factor), IGF-I (insulin-like growth factor-I), and TGF-β (transforming growth factor-β) as a cytokine that suppresses hair growth. )and so on. Therefore, it suppresses the growth of body hair by suppressing the production of cytokines that promote hair growth such as HGF produced by the hair papilla, or by promoting the production of cytokines that suppress hair growth such as TGF-β. It is considered possible.
本発明者等はこのような点に着目し、各種植物抽出物の毛成長抑制作用や毛成長促進作用について鋭意検討した結果、イラクサ抽出物が毛乳頭によるTGF−βの産生を促進し、またヒオウギ抽出物が毛乳頭によるHGFの産生を抑制することを見出し、これらを併用することに着目して本発明を完成するに至った。 The present inventors pay attention to such points, and as a result of intensive studies on the hair growth inhibiting action and hair growth promoting action of various plant extracts, the nettle extract promotes the production of TGF-β by the hair papilla, The present invention has been completed by focusing on the combined use of these extracts with the ability to extract HGF by hair papilla.
すなわち請求項1記載の発明は、毛成長抑制剤に、イラクサ抽出物とヒオウギ抽出物とを有効成分として含有させたことを特徴とする。ここで「イラクサ抽出物とヒオウギ抽出物とを有効成分として含有する」とは、毛成長抑制剤がイラクサ抽出物とヒオウギ抽出物のみからなっていてもよく、またイラクサ抽出物、ヒオウギ抽出物以外の成分を含んでいてもよいことを意味する。 That is, the invention described in claim 1 is characterized in that the hair growth inhibitor contains the nettle extract and the cedar extract as active ingredients. Here, “contains nettle extract and capsicum extract as active ingredients” means that the hair growth inhibitor may consist of nettle extract and capsicum extract alone, and other than nettle extract and capsicum extract It means that the component of this may be included.
また請求項2記載の発明は、請求項1記載の毛成長抑制剤を配合したことを特徴とする皮膚外用剤の発明である。さらに、請求項3記載の発明は、請求項1記載の毛成長抑制剤組成物を配合したことを特徴とする化粧料の発明である。 The invention described in claim 2 is an invention for an external preparation for skin, wherein the hair growth inhibitor described in claim 1 is blended. Furthermore, invention of Claim 3 is invention of the cosmetics characterized by mix | blending the hair growth inhibitor composition of Claim 1.
本発明によって、優れた毛成長抑制効果を有し、人体に対して安全性の高い毛成長抑制剤、及びその毛成長抑制剤を配合した皮膚外用剤、化粧料を提供することが可能となった。 According to the present invention, it is possible to provide a hair growth inhibitor that has an excellent hair growth inhibitory effect and is highly safe for the human body, and an external preparation for skin and a cosmetic that contain the hair growth inhibitor. It was.
本発明の毛成長抑制剤における有効成分の1つであるイラクサ(Urtica thubergiana Siebold et)は、イラクサ科に属し、本州、四国、九州に分布する多年草の植物である。一方、他の有効成分であるヒオウギ(Belamcanda chinensis D.C)は、アヤメ科、ヒオウギ属に属する植物である。 Nettle (Urtica thubergiana Siebold et), one of the active ingredients in the hair growth inhibitor of the present invention, belongs to the nettle family and is a perennial plant distributed in Honshu, Shikoku and Kyushu. On the other hand, the other active ingredient, Higashigi (Belamcanda chinensis D.C), is a plant belonging to the family Iridaceae and the genus Hiogi.
本発明で用いられる抽出物とは、イラクサやヒオウギの粉砕物を、常温または加温下に溶剤により抽出するか、または、ソックスレー抽出器等の抽出器具を用いて抽出することにより得られる各種溶媒抽出液、その希釈液、その濃縮液、あるいはその乾燥末を意味するものである。抽出材料となる植物(イラクサ、ヒオウギ)の部位は特に限定されるものではないが、イラクサの場合は葉を材料とするのが好ましく、ヒオウギの場合は根茎を材料とするのが好ましい。 The extract used in the present invention is a variety of solvents obtained by extracting nettle and cedar pulverized products with a solvent at room temperature or under heating, or by using an extractor such as a Soxhlet extractor. It means the extract, its diluted solution, its concentrated solution, or its dry powder. The site of the plant (nettle, cypress) to be the extraction material is not particularly limited, but in the case of nettle, it is preferable to use leaves, and in the case of cypress, it is preferable to use rhizomes.
抽出に用いる溶媒としては、通常の植物の抽出に用いられる溶媒であれば任意に用いることができる。例えば、水、メタノール、エタノール、プロピレングリコール、1,3−ブチレングリコール、グリセリン等のアルコール類、含水アルコール類、クロロホルム、ジクロルエタン、四塩化炭素、アセトン、酢酸エチル、ヘキサン等の有機溶媒類等であり、それらは単独あるいは組み合わせて用いることができる。 As a solvent used for extraction, any solvent can be used as long as it is a solvent used for normal plant extraction. For example, water, alcohols such as methanol, ethanol, propylene glycol, 1,3-butylene glycol, glycerin, hydrous alcohols, organic solvents such as chloroform, dichloroethane, carbon tetrachloride, acetone, ethyl acetate, hexane, etc. They can be used alone or in combination.
上記のような毛成長抑制剤を配合した本発明の皮膚外用剤、化粧料は、ゲル状、ローション等の液状、クリーム状、エアゾール等の剤型にすることができるが、これらの剤型に限定されるものではない。皮膚外用剤としては、たとえば医薬部外品や医薬品等に適用するものが用いられる。 The external preparation for skin and cosmetics of the present invention containing the hair growth inhibitor as described above can be made into gel, lotion and other liquid forms, cream forms, aerosol forms, etc. It is not limited. As a skin external preparation, what is applied to a quasi drug, a pharmaceutical, etc. is used, for example.
本発明の皮膚外用剤、化粧料中のイラクサ抽出物やヒオウギ抽出物の配合量は、通常乾燥固形分として0.0001〜50重量%とすることが好ましい。0.0001重量%未満では本発明の効果が充分に得られない可能性があり、一方、50重量%を越えても、その増量に見合った効果の向上は認められないからである。この観点からは、0.001〜10重量%が特に好ましい。 It is preferable that the compounding quantity of the nettle extract and the herb extract in the external preparation for skin and cosmetics of the present invention is usually 0.0001 to 50% by weight as a dry solid content. If the amount is less than 0.0001% by weight, the effect of the present invention may not be sufficiently obtained. On the other hand, if the amount exceeds 50% by weight, an improvement in the effect commensurate with the increase is not recognized. From this viewpoint, 0.001 to 10% by weight is particularly preferable.
本発明の皮膚外用剤や化粧料には、本発明の効果を損なわない範囲において、一般に化粧料に用いられ、或いは医薬部外品や医薬品等の皮膚外用剤に用いられる各種任意成分を必要に応じて適宜配合することができる。このような任意成分としては、例えば、精製水、エタノール、油性成分、保湿剤、増粘剤、防腐剤、乳化剤、薬効成分、粉体、紫外線吸収剤、色素、香料、乳化安定剤等を挙げることができる。 The skin external preparation and cosmetics of the present invention require various optional ingredients that are generally used in cosmetics or used in skin external preparations such as quasi-drugs and pharmaceuticals, as long as the effects of the present invention are not impaired. It can mix | blend suitably according to it. Examples of such optional components include purified water, ethanol, oily components, humectants, thickeners, preservatives, emulsifiers, medicinal components, powders, ultraviolet absorbers, dyes, fragrances, and emulsion stabilizers. be able to.
以下、本発明の実施例について説明する。
(実施例1)
本実施例の毛成長抑制剤は、イラクサ(Urtica thubergiana Siebold et)の葉の抽出成分及びヒオウギ(Belamcanda chinensis D.C)の根茎の抽出成分からなるものである。
Examples of the present invention will be described below.
(Example 1)
The hair growth inhibitor of this example is composed of an extract component of nettle (Urtica thubergiana Siebold et) leaves and an extract component of rhizomes of bean (Belamcanda chinensis DC).
その1つの製造例について説明すると、イラクサの葉(乾燥物)200gを2L の50%エタノール溶液に浸漬し、60〜80℃で2日間抽出し、抽出液から溶媒を除去し、15.8gの抽出物を得た。また、ヒオウギの根茎(乾燥物)200gを2L の50%エタノール溶液に浸漬し、60〜80℃で2日間抽出し、抽出液から溶媒を除去し、12.1gの抽出物を得た。抽出物の量は、乾燥固形分としての値で示している。 One example of production will be described. 200 g of nettle leaves (dried material) are immersed in 2 L of a 50% ethanol solution, extracted at 60-80 ° C. for 2 days, the solvent is removed from the extract, and 15.8 g of An extract was obtained. Moreover, 200 g of rhinoceros rhizome (dried product) was immersed in 2 L of 50% ethanol solution and extracted at 60 to 80 ° C. for 2 days, and the solvent was removed from the extract to obtain 12.1 g of extract. The amount of the extract is shown as a value as a dry solid content.
(試験例1)
〔ヒト毛乳頭細胞のTGF−β産生能及びHGF産生抑制能に対する作用試験〕
ヒト毛乳頭細胞を12wellプレートに2×104 /wellで播種し、10%牛胎児血清(FBS)を添加したダルベッコ変法MEM培地(DMEM培地)で5日間培養した。培養5日目にDMEM培地で細胞を洗浄した後、0.001重量%のイラクサ抽出物及び0.001重量%のヒオウギ抽出物を含むDMEMに培地を交換し、さらに培養を続けた。
(Test Example 1)
[Effect of human hair papilla cells on TGF-β production ability and HGF production inhibition ability]
Human hair papilla cells were seeded at 2 × 10 4 / well in a 12-well plate and cultured in Dulbecco's modified MEM medium (DMEM medium) supplemented with 10% fetal bovine serum (FBS) for 5 days. After washing the cells with DMEM medium on the 5th day of culture, the medium was replaced with DMEM containing 0.001% by weight of nettle extract and 0.001% by weight of cypress extract, and the culture was further continued.
3日間培養した後、培養上澄を回収し、培養上澄に含まれるTGF−βの量を、ヒトTGF−β Immunoassay キット(GT社製)を用いてELISA法により測定した。また培養上澄に含まれるHGFの量を、ヒトHGF Immunoassay キット(GT社製)を用いてELISA法により測定した。
イラクサ抽出物、ヒオウギ抽出物のTGF−β産生促進効果及びHGF産生抑制は、DMEM培地のみで培養した場合のTGF−β量、HGF量を100とした場合の値(比率)で示した。その結果を表1に示す。
After culturing for 3 days, the culture supernatant was collected, and the amount of TGF-β contained in the culture supernatant was measured by ELISA using a human TGF-β Immunoassay kit (manufactured by GT). The amount of HGF contained in the culture supernatant was measured by ELISA using a human HGF Immunoassay kit (manufactured by GT).
The effect of promoting the production of TGF-β and the suppression of the production of HGF by the extract of nettle extract and the extract of Hagigi were shown as values (ratio) when the amount of TGF-β and the amount of HGF were set to 100 when cultured in only DMEM medium. The results are shown in Table 1.
表1からも明らかなように、イラクサ抽出物を含むDMEM培地で培養したヒト毛乳頭細胞から産生されたTGF−β量は、抽出物を含まないDMEM培地(コントロール)で培養したヒト毛乳頭細胞から産生されたTGF−β量よりも増加していた。ただしヒオウギ抽出物を含むDMEM培地で培養したヒト毛乳頭細胞から産生されたTGF−β量は、コントロールの場合と同じであった。このことから、ヒオウギ抽出物は毛乳頭細胞によるTGF−β産生を促進するものとは認められないが、イラクサ抽出物は毛乳頭細胞によるTGF−β産生を促進するものと認められた。 As is clear from Table 1, the amount of TGF-β produced from human hair papilla cells cultured in a DMEM medium containing nettle extract is equal to the amount of human hair papilla cells cultured in a DMEM medium (control) containing no extract. Increased from the amount of TGF-β produced from. However, the amount of TGF-β produced from human dermal papilla cells cultured in a DMEM medium containing a barley extract was the same as that in the control. From this, it was recognized that the Hiragi extract promotes TGF-β production by hair papilla cells, but the nettle extract promotes TGF-β production by hair papilla cells.
一方、イラクサ抽出物を含むDMEM培地で培養したヒト毛乳頭細胞から産生されたHGF量は、コントロールのDMEM培地で培養したヒト毛乳頭細胞から産生されたHGF量と同じであったが、ヒオウギ抽出物を含むDMEM培地で培養したヒト毛乳頭細胞から産生されたHGF量は、コントロールの場合よりも著しく減少していた。このことから、イラクサ抽出物は毛乳頭細胞によるHGF産生を抑制するものとは認められないが、ヒオウギ抽出物は毛乳頭細胞によるHGF産生を抑制するものと認められた。 On the other hand, the amount of HGF produced from human hair papilla cells cultured in DMEM medium containing nettle extract was the same as the amount of HGF produced from human hair papilla cells cultured in control DMEM medium. The amount of HGF produced from human hair papilla cells cultured in the DMEM medium containing the product was significantly reduced as compared with the control. From this, it was recognized that the nettle extract does not suppress HGF production by hair papilla cells, but the barley extract suppresses HGF production by hair papilla cells.
(試験例2)
〔マウスを用いた毛成長抑制作用試験〕
C3H/Heマウス(8週齢、雄)の背部を剃毛し、1日に1回、0.01重量%のイラクサ抽出物を含む50%エタノール溶液、0.01重量%のヒオウギ抽出物を含む50%エタノール溶液、並びに0.01重量%のイラクサ抽出物と0.01重量%のヒオウギ抽出物とを含む50%エタノール溶液を、それぞれ0.1mlずつ、20日間塗布した。一方、上記の抽出物を含まない50%エタノール溶液を、同様にC3H/Heマウスの背部に1日に1回塗布し、これを対照群とした。これらの毛成長抑制効果を、剃毛後20日目における剃毛部の毛再生面積率を比較することにより調べた。その結果を表2に示す。
(Test Example 2)
[Hair growth inhibition test using mice]
The back of C3H / He mice (8 weeks old, male) was shaved, and once a day, a 50% ethanol solution containing 0.01% by weight of nettle extract and 0.01% by weight of barley extract were used. A 50% ethanol solution containing 0.1% by weight of a 50% ethanol solution containing 0.01% by weight of a nettle extract and 0.01% by weight of a barley extract was applied for 20 days. On the other hand, the 50% ethanol solution not containing the above extract was similarly applied once a day to the back of C3H / He mice, and this was used as a control group. These hair growth inhibitory effects were examined by comparing the hair regeneration area ratio of the shaved portion on the 20th day after shaving. The results are shown in Table 2.
表2からも明らかなように、対照群では毛再生面積が88%であったのに対し、0.01重量%のイラクサ抽出物を含む50%エタノール溶液を塗布したC3H/Heマウス(イラクサ抽出物塗布群)では毛再生面積が39%、0.01重量%のヒオウギ抽出物を含む50%エタノール溶液を塗布したC3H/Heマウス(ヒオウギ抽出物塗布群)では毛再生面積が52%であり、いずれも対照群に比べて著しく毛再生面積が小さかった。このことから、イラクサ抽出物及びヒオウギ抽出物はいずれもマウスの毛成長の抑制効果が非常に良好であると認められた。 As apparent from Table 2, the hair regeneration area in the control group was 88%, whereas C3H / He mice (nettle extract) coated with a 50% ethanol solution containing 0.01% by weight of nettle extract were used. In the product application group), the hair regeneration area was 39%, and in the C3H / He mice (application group of the cedar extract) coated with a 50% ethanol solution containing 0.01% by weight of the peony extract, the hair regrowth area was 52%. In both cases, the hair regeneration area was remarkably small compared to the control group. From this, it was recognized that both the nettle extract and the cedar extract have a very good inhibitory effect on mouse hair growth.
さらに、0.01重量%のイラクサ抽出物と0.01重量%のヒオウギ抽出物との双方を含む50%エタノール溶液を塗布したC3H/Heマウス(イラクサ+ヒオウギ抽出物塗布群)では、対照群はもちろんのこと、イラクサ抽出物塗布群及びヒオウギ抽出物塗布群に比べても毛再生面積が狭かった。このことから、イラクサ抽出物とヒオウギ抽出物との相乗効果によって、マウスの毛成長の抑制効果が一層良好になるものと認められた。 Furthermore, in the C3H / He mice (nettle + peel extract application group) coated with a 50% ethanol solution containing both 0.01% by weight nettle extract and 0.01% by weight birch extract, the control group Needless to say, the hair regeneration area was narrower than that of the nettle extract application group and the cypress extract application group. From this, it was recognized that the inhibitory effect of mouse hair growth was further improved by the synergistic effect of the nettle extract and the cedar extract.
(処方例1)
本処方例は、化粧料の一例としてのスキンケアローションの処方例であり、その組成は次のとおりである。
(Prescription Example 1)
This prescription example is a prescription example of a skin care lotion as an example of a cosmetic, and its composition is as follows.
配合成分 重量%
エタノール 5.0
1,3−ブチレングリコール 7.0
ソルビット液 10.0
イラクサ抽出物 0.01
ヒオウギ抽出物 0.01
パラオキシ安息香酸メチル 0.15
クエン酸 0.05
クエン酸ナトリウム 0.2
エデト酸塩 0.05
香料 0.1
POE硬化ヒマシ油 0.5
精製水 残量
Compounding ingredients Weight%
Ethanol 5.0
1,3-butylene glycol 7.0
Sorbit solution 10.0
Nettle extract 0.01
Hinogi extract 0.01
Methyl paraoxybenzoate 0.15
Citric acid 0.05
Sodium citrate 0.2
Edetate 0.05
Fragrance 0.1
POE hydrogenated castor oil 0.5
Purified water remaining
(処方例2)
本処方例は、化粧料の一例としてのスキンケアクリームの処方例であり、その組成は次のとおりである。
(Prescription example 2)
This prescription example is a prescription example of a skin care cream as an example of a cosmetic, and its composition is as follows.
配合成分 重量%
セタノール 2.5
スクワラン 10.0
サラシミツロウ 1.0
トリオクタン酸グリセリル 5.0
ミリスチン酸オクチルドデシル 15.0
酢酸トコフェロール 0.1
1,3−ブチレングリコール 7.0
モノステアリン酸グリセリン 3.0
POE(20)ソルビタンモノステアレート 1.0
ソルビタンモノステアレート 2.0
イラクサ抽出物 0.1
ヒオウギ抽出物 0.1
濃グリセリン 5.0
パラオキシ安息香酸ブチル 0.1
パラオキシ安息香酸メチル 0.2
精製水 残量
Compounding ingredients Weight%
Cetanol 2.5
Squalane 10.0
Sara honey bee 1.0
Glyceryl trioctanoate 5.0
Octyldodecyl myristate 15.0
Tocopherol acetate 0.1
1,3-butylene glycol 7.0
Glycerol monostearate 3.0
POE (20) sorbitan monostearate 1.0
Sorbitan monostearate 2.0
Nettle extract 0.1
Hinogi extract 0.1
Concentrated glycerin 5.0
Butyl paraoxybenzoate 0.1
Methyl paraoxybenzoate 0.2
Purified water remaining
本発明の毛成長抑制剤は、皮膚外用剤、化粧料等に広く適用することができる。 The hair growth inhibitor of the present invention can be widely applied to external preparations for skin, cosmetics and the like.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004150246A JP2005330228A (en) | 2004-05-20 | 2004-05-20 | Hair growth inhibitor, skin care preparation and cosmetic each compounded therewith |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004150246A JP2005330228A (en) | 2004-05-20 | 2004-05-20 | Hair growth inhibitor, skin care preparation and cosmetic each compounded therewith |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2005330228A true JP2005330228A (en) | 2005-12-02 |
Family
ID=35485131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004150246A Pending JP2005330228A (en) | 2004-05-20 | 2004-05-20 | Hair growth inhibitor, skin care preparation and cosmetic each compounded therewith |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005330228A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010007553A3 (en) * | 2008-07-15 | 2010-03-11 | Tropical Sky Trading 156 Cc | A composition for the removal of hair from human body |
| JP2010095496A (en) * | 2008-10-20 | 2010-04-30 | Pias Arise Kk | Production conditioner for hair-growing cytokine, and hair grower, quasi-drug and cosmetic each incorporated with production conditioner for growing the cytokine |
| JP2013213039A (en) * | 2013-06-21 | 2013-10-17 | Pias Arise Kk | Production conditioner for hair-growing cytokine, and hair-growing agent, quasi-drug and cosmetic each having incorporated the production conditioner for cytokine therewith |
| US9216304B2 (en) | 2010-03-26 | 2015-12-22 | The Gillette Company | Method of depilation and depilatory kit |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01168261A (en) * | 1987-03-11 | 1989-07-03 | Arcopharma Ltd | Composition of oats and nettle extracts |
| JPH03188013A (en) * | 1989-12-15 | 1991-08-16 | Shiseido Co Ltd | Testosterone-5alpha-reductase inhibitor |
| JPH04211013A (en) * | 1990-02-16 | 1992-08-03 | Kanoldt Arzneimittel Gmbh | Drug containing stigmasta-4-ene-3-one and its use |
| JPH07277930A (en) * | 1994-04-05 | 1995-10-24 | Shiseido Co Ltd | Hair growth material |
| JPH11322548A (en) * | 1998-05-14 | 1999-11-24 | Ichimaru Pharcos Co Ltd | Trichogenesis inhibitor |
| US6113926A (en) * | 1995-08-09 | 2000-09-05 | Soler; Josecabo | Composition and topical formulation of antiandrogens of natural (plant) origin |
| JP2001261571A (en) * | 2000-03-14 | 2001-09-26 | Api Co Ltd | Propolis composition |
| JP2001288095A (en) * | 2000-04-07 | 2001-10-16 | Ain:Kk | Hair growth inhibitor for body hair |
| JP2002047194A (en) * | 2000-08-01 | 2002-02-12 | Noevir Co Ltd | Microbial lipase inhibitor, skin care preparation for common acne and skin care preparation for dandruff comprising the same |
| WO2003022207A2 (en) * | 2001-09-07 | 2003-03-20 | Niazi Sarfaraz K | Method and composition for reducing sebum secretion in mammals |
| JP2003128563A (en) * | 2001-10-25 | 2003-05-08 | Ichimaru Pharcos Co Ltd | Cosmetic composition, drink or food |
| JP2003137747A (en) * | 2001-11-06 | 2003-05-14 | Picaso Cosmetic Laboratory Ltd | Hair growth suppressor |
-
2004
- 2004-05-20 JP JP2004150246A patent/JP2005330228A/en active Pending
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01168261A (en) * | 1987-03-11 | 1989-07-03 | Arcopharma Ltd | Composition of oats and nettle extracts |
| JPH03188013A (en) * | 1989-12-15 | 1991-08-16 | Shiseido Co Ltd | Testosterone-5alpha-reductase inhibitor |
| JPH04211013A (en) * | 1990-02-16 | 1992-08-03 | Kanoldt Arzneimittel Gmbh | Drug containing stigmasta-4-ene-3-one and its use |
| JPH07277930A (en) * | 1994-04-05 | 1995-10-24 | Shiseido Co Ltd | Hair growth material |
| US6113926A (en) * | 1995-08-09 | 2000-09-05 | Soler; Josecabo | Composition and topical formulation of antiandrogens of natural (plant) origin |
| JPH11322548A (en) * | 1998-05-14 | 1999-11-24 | Ichimaru Pharcos Co Ltd | Trichogenesis inhibitor |
| JP2001261571A (en) * | 2000-03-14 | 2001-09-26 | Api Co Ltd | Propolis composition |
| JP2001288095A (en) * | 2000-04-07 | 2001-10-16 | Ain:Kk | Hair growth inhibitor for body hair |
| JP2002047194A (en) * | 2000-08-01 | 2002-02-12 | Noevir Co Ltd | Microbial lipase inhibitor, skin care preparation for common acne and skin care preparation for dandruff comprising the same |
| WO2003022207A2 (en) * | 2001-09-07 | 2003-03-20 | Niazi Sarfaraz K | Method and composition for reducing sebum secretion in mammals |
| JP2003128563A (en) * | 2001-10-25 | 2003-05-08 | Ichimaru Pharcos Co Ltd | Cosmetic composition, drink or food |
| JP2003137747A (en) * | 2001-11-06 | 2003-05-14 | Picaso Cosmetic Laboratory Ltd | Hair growth suppressor |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010007553A3 (en) * | 2008-07-15 | 2010-03-11 | Tropical Sky Trading 156 Cc | A composition for the removal of hair from human body |
| JP2010095496A (en) * | 2008-10-20 | 2010-04-30 | Pias Arise Kk | Production conditioner for hair-growing cytokine, and hair grower, quasi-drug and cosmetic each incorporated with production conditioner for growing the cytokine |
| US9216304B2 (en) | 2010-03-26 | 2015-12-22 | The Gillette Company | Method of depilation and depilatory kit |
| JP2013213039A (en) * | 2013-06-21 | 2013-10-17 | Pias Arise Kk | Production conditioner for hair-growing cytokine, and hair-growing agent, quasi-drug and cosmetic each having incorporated the production conditioner for cytokine therewith |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7421464B2 (en) | Scalp preparation | |
| JP2009108015A (en) | Inhibitor of stretch-mediated melanin production | |
| JP2010184916A (en) | Hair growth promoter | |
| JP2004345959A (en) | Melanogenesis promoter and melanogenesis-promoting composition | |
| JP2012020950A (en) | Inhibitor of endothelin action and whitening agent | |
| JP4460420B2 (en) | Collagen production promoter | |
| JP4027949B2 (en) | Hair nourishing agent | |
| JP3742767B2 (en) | Hair conditioner consisting of extracts of Asagaokakaraksa and other herbal extracts | |
| JP3908245B2 (en) | Hair nourishing agent | |
| JP2005330228A (en) | Hair growth inhibitor, skin care preparation and cosmetic each compounded therewith | |
| JP2002332240A (en) | Hair grower composition | |
| WO2002051374A1 (en) | Hair growth inhibitors and compositions containing the same | |
| JP3441722B2 (en) | Cosmetics | |
| JP4113518B2 (en) | TGF-β production promoter for suppressing hair growth of body hair | |
| JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
| JPH1017456A (en) | Cell-activating agent, cosmetic and hair-growing agent | |
| JP4921732B2 (en) | Melanin synthesis promoter and topical skin preparation | |
| JP4754834B2 (en) | Cosmetics | |
| JP2002284648A (en) | Hair restorer composition | |
| JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
| JP2010095496A (en) | Production conditioner for hair-growing cytokine, and hair grower, quasi-drug and cosmetic each incorporated with production conditioner for growing the cytokine | |
| JP2001072567A (en) | Skin cosmetic | |
| JP2006028071A (en) | Proteoglycan production promoter | |
| JP5405782B2 (en) | Ceramide production promoter and moisturizer | |
| JP6017259B2 (en) | Endothelin action inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080620 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090109 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090327 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090717 |